EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

Antibiotic Resistance Among Uropathogenic Escherichia coli

Barbara Kot

Polish Journal of Microbiology · 01.12.2019 · 68 (4) · 403-415

DOI: 10.33073/pjm-2019-048 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Polish Journal of Microbiology, online erschienen am 05.12.2019. Verfasst von Barbara Kot. Beteiligte Einrichtung: Department of Microbiology, Faculty of Natural Sciences, Siedlce University of Natural Sciences and Humanities , Siedlce , Poland. Hauptthemen laut MEDLINE: Drug Resistance, Bacterial. Die Arbeit wurde bisher 238-mal zitiert (Crossref) und nennt 102 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Urinary tract infections (UTIs) belong to the most common community-acquired and nosocomial infections. A main etiological factor of UTIs is uropathogenic Escherichia coli (UPEC). This review describes the current state of knowledge on the resistance of UPEC to antibiotics recommended for the treatment of UTIs based on the available literature data. Nitrofurantoin and fosfomycin are recommended as first-line therapy in the treatment of uncomplicated cystitis, and the resistance to these antimicrobial agents remains low between UPEC. Recently, in many countries, the increasing resistance is observed to trimethoprim-sulfamethoxazole, which is widely used as the first-line antimicrobial in the treatment of uncomplicated UTIs. In European countries, the resistance of UPEC to this antimicrobial agent ranges from 14.6% to 60%. The widespread use of fluoroquinolones (FQs), especially ciprofloxacin, in the outpatients is the cause of a continuous increase in resistance to these drugs. The resistance of UPEC to FQs is significantly higher in developing countries (55.5–85.5%) than in developed countries (5.1–32.0%). Amoxicillin-clavulanic acid is recommended as first line-therapy for pyelonephritis or complicated UTI. Resistance rates of UPEC to amoxicillin-clavulanic acid are regionally variable. In European countries the level of resistance to this antimicrobial ranges from 5.3% (Germany) to 37.6% (France). Increasing rates of UPEC resistance to antimicrobials indicate that careful monitoring of their use for UTI treatment is necessary.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Drug Resistance, BacterialAnimalsAnti-Bacterial AgentsEscherichia coli InfectionsHumansUrinary Tract InfectionsUropathogenic Escherichia coli

Substanzen

Anti-Bacterial Agents

Autor:innen und Institutionen

  • Department of Microbiology, Faculty of Natural Sciences, Siedlce University of Natural Sciences and Humanities , Siedlce , Poland.

Zitieren

APA

Kot, B. (2019). Antibiotic Resistance Among Uropathogenic Escherichia coli. Polish Journal of Microbiology, 68(4), 403-415. https://doi.org/10.33073/pjm-2019-048

Vancouver

Kot B. Antibiotic Resistance Among Uropathogenic Escherichia coli. Polish Journal of Microbiology. 2019;68(4):403-415. doi:10.33073/pjm-2019-048

BibTeX
@article{Kot2019,
  author = {Kot, Barbara},
  title = {Antibiotic Resistance Among Uropathogenic Escherichia coli},
  journal = {Polish Journal of Microbiology},
  year = {2019},
  volume = {68},
  number = {4},
  pages = {403--415},
  doi = {10.33073/pjm-2019-048}
}
Kostenlos starten →